Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation

Dirk Foell1, Michael Frosch, Clemens Sorg

  • 1Department of Pediatrics, University of Münster, Münster, Germany. dfoell@uni-muenster.de

Insights

Phagocyte-specific S100 proteins (S100A8, S100A9, S100A12) are pro-inflammatory and useful biomarkers for detecting and monitoring various inflammatory conditions, including arthritis and inflammatory bowel disease.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • S100 proteins are the largest family of calcium-binding proteins.
  • Phagocyte-specific S100 proteins (S100A8, S100A9, S100A12) are pro-inflammatory molecules crucial to the innate immune system.
  • These proteins are implicated in the pro-inflammatory axis of various inflammatory conditions.

Purpose of the Study:

  • To review the pro-inflammatory functions of S100 proteins.
  • To highlight the utility of S100 proteins as biomarkers for inflammation.
  • To discuss their role in monitoring disease activity and treatment response.

Main Methods:

  • Literature review of studies on S100 proteins and inflammation.
  • Analysis of S100 protein expression and concentration in inflammatory conditions.
  • Evaluation of S100 proteins as diagnostic and prognostic markers.

Main Results:

  • S100A8, S100A9, and S100A12 are overexpressed at inflammatory sites and found in high concentrations in bodily fluids.
  • The S100A8/S100A9 complex and S100A12 are effective diagnostic markers for non-infectious inflammatory diseases like arthritis and inflammatory bowel disease.
  • These proteins indicate phagocyte activation more sensitively than conventional markers and can detect minimal residual inflammation.

Conclusions:

  • Phagocyte-specific S100 proteins are valuable biomarkers for inflammation.
  • They offer sensitive detection of disease activity and response to treatment.
  • S100 proteins may serve as prospective markers for patient outcomes in inflammatory disorders.